Did you know the five-year relative survival rate for stage 1 colorectal cancer (CRC) is 92 percent?

While that’s good news, research indicates that less than 40 percent of adults are not up to date with preventive screening for this disease. CRC screening reduces mortality from this type of cancer by up to 33 percent and last year alone, BioIQ screened over 250,000 people by partnering with health plans and employers to distribute easy-to-use, at-home test kits.

In the video below, BioIQ’s Chief Medical Officer Josh Sclar, MD, MPH, explains why our comprehensive CRC testing programs are a great example of high-impact prevention at scale. Leveraging tailored engagement strategies, convenient at-home testing solutions and physician-led models that foster payer-provider collaboration, BioIQ helps health plans close CRC gaps and enables employers to identify employees at risk of CRC earlier and guide them to the next steps in care.

 

To learn how BioIQ can help your organization can implement an effective CRC screening program, contact (888) 818-1594 or sales@bioiq.com.

Share This